货号:A547954
同义名:
嘌呤霉素二盐酸盐水合物
/ CL13900 dihydrochloride; Puromycin(hydrochloride)
Puromycin 2HCl 是一种氨基核苷类抗生素,作为蛋白质合成抑制剂,在选择性表达转染pac基因(白链霉菌)的哺乳动物细胞系中,其产物嘌呤霉素乙酰转移酶通过乙酰化使药物失活,诱导胸腺细胞和HL-60白血病细胞内DNA断裂。(转染哺乳动物细胞的推荐范围为1-30 µg/ml。)


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | Puromycin (2HCl), an aminonucleoside antibiotic, inhibits protein synthesis. Puromycin (2HCl), an analog of the 3' end of aminoacyl-tRNA, causes premature termination of translation by being linked non-specifically to growing polypeptide chains. Puromycin acting as a non-inhibitor at very low concentration (e.g. 0.04 microM) can bond only to full-length protein at the C-terminus. Puromycin and its derivatives at concentrations lower than those able to compete effectively with aminoacyl-tRNA can bond specifically to full-length protein at a stop codon[3]. Puromycin is a peptidyl nucleoside endowed with significant antibiotic and anticancer properties, but also with an unfortunate nephrotoxic character that has hampered its use as a chemotherapeutic agent[4]. Moreover, puromycin is a damaging agent known to induce apoptosis in mammalian cells. Puromycin-induced apoptosis in S. cerevisiae[5]. Carbocyclic puromycin was equal to puromycin when evaluated for cytotoxicity using P-388 mouse lymphoid leukemia cells in culture[6]. |
| Concentration | Treated Time | Description | References | |
| CD4+ T cells | 5 μg/mL | Inhibited the proliferation of CD4+ T cells and reduced their pathogenicity | Nat Commun. 2022 Oct 4;13(1):5866. | |
| Mouse primary myotubes | 10 μg/mL | 10 min | To measure protein synthesis levels, results showed increased puromycin incorporation, indicating enhanced protein synthesis. | Skelet Muscle. 2019 Oct 31;9(1):26. |
| E14 mouse embryonic stem cells | 1 μg/ml | 48 h | To select clones transduced with Nm-gRNA | Cell Death Discov. 2023 Feb 13;9(1):61. |
| FaDu cells | 2 μg/ml | 1 week | To screen stably silenced and overexpressed IGF2BP2 HNSCC cells | J Exp Clin Cancer Res. 2022 Jan 3;41(1):6. |
| SCC15 cells | 2 μg/ml | 1 week | To screen stably silenced and overexpressed IGF2BP2 HNSCC cells | J Exp Clin Cancer Res. 2022 Jan 3;41(1):6. |
| Administration | Dosage | Frequency | Description | References | ||
| Mice | Experimental autoimmune uveitis (EAU) model | Added to the culture medium | 5 μg/mL | Used to select transduced cells and inhibit the proliferation of CD4+ T cells | Nat Commun. 2022 Oct 4;13(1):5866. | |
| Mice | SCID mice | Intraperitoneal injection | 0.040 μM | Single injection, lasting 30 minutes | To measure muscle protein synthesis levels, results showed increased puromycin incorporation, indicating enhanced protein synthesis. | Skelet Muscle. 2019 Oct 31;9(1):26. |
| Mouse | LONP1 mKO mice | Intraperitoneal injection | 0.04 mmol/g | Single injection, lasting 30 minutes | Measure in vivo protein synthesis rates | Nat Commun. 2022 Feb 16;13(1):894 |
| Mice | SIRT6 heterozygous mice | Intraperitoneal injection | 40 nmol/g | Single injection, sacrificed after 30 minutes | To measure in vivo protein synthesis rates | Nucleic Acids Res. 2019 Sep 26;47(17):9115-9131 |
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT01132183 | Healthy | Phase 1 | Completed | - | India ... 展开 >> Bioserve Clinical Research Pvt. Ltd. Hyd, Andhra Pradesh, India, 500 037 收起 << |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
1.84mL 0.37mL 0.18mL |
9.18mL 1.84mL 0.92mL |
18.37mL 3.67mL 1.84mL |
|
| CAS号 | 58-58-2 |
| 分子式 | C22H31Cl2N7O5 |
| 分子量 | 544.43 |
| SMILES Code | OC[C@@H]1[C@@H](NC([C@@H](N)CC2=CC=C(OC)C=C2)=O)[C@H]([C@H](N3C=NC4=C3N=CN=C4N(C)C)O1)O.[H]Cl.[H]Cl |
| MDL No. | MFCD00012691 |
| 别名 | 嘌呤霉素二盐酸盐水合物 ;CL13900 dihydrochloride; Puromycin(hydrochloride); PDH; NSC 3055; CL13900 2HCl; Puromycin 2HCl; Puromycin(dihydrochloride) |
| 运输 | 蓝冰 |
| InChI Key | MKSVFGKWZLUTTO-FZFAUISWSA-N |
| Pubchem ID | 443311 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Inert atmosphere, store in freezer, under -20°C |
| 溶解方案 |
DMSO: 25 mg/mL(45.92 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 50 mg/mL(91.84 mM) 无水乙醇: 5 mg/mL(9.18 mM),配合低频超声,并水浴加热至45℃助溶,注意:无水乙醇开封后,易挥发,也会吸收空气中的水分,导致溶解能力下降,请避免使用开封较久的乙醇 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1